Here’s why biotech UniQure’s stock just tripled, and brought ClearPoint shares up with itBy Mario Cazombo / September 24, 2025 A ClearPoint Neuro’s medical device plays an important role in UniQure’s effort to battle Huntington’s disease.
Book Review: The Financial Restructuring Tool Set August 6, 2025 / Book Reviews, Corporate Finance, Drivers of Value, Economics, Financial Statement Analysis, General
